Table 1.
Patient's sociodemographic and medical characteristics at baseline
| Characteristics | Inpatient rehabilitation (IR) n=133 (54.3%) | Control with Advice (A+) n=30 (12.2%) |
Control - No advice (A-) n=82 (33.5%) |
p IR vs. A+ |
p IR vs. A- |
p A+ vs. A- |
|---|---|---|---|---|---|---|
| Age in years (M /IQR) a | 62.0 (+/- 14.0) | 57.5 (+/- 19.0) | 59.0 (+/- 19.0) | 0.020 | 0.012 | 0.610 |
| Hospital stay in days (M /IQR) b | 18.0 (+/- 9.0) | 18.5 (+/- 12.0) | 8.5 (+/- 8.0) | 0.709 | <0.001 | <0.001 |
| Sex (%) | ||||||
| Male | 78 (59%) | 19 (63%) | 36 (44%) | 0.637 | 0.035 | 0.069 |
| Living (%) | ||||||
| Alone | 42 (32%) | 8 (27%) | 17 (21%) | 0.598 | 0.083 | 0.504 |
| Children in household (%) | ||||||
| Yes | 18 (14%) | 6 (20%) | 13 (16%) | 0.367 | 0.638 | 0.605 |
| Level of education (%) | 0.372 | 0.816 | 0.698 | |||
| Basic school (8-9 years) | 9 (7%) | 4 (13%) | 8 (10%) | |||
| Vocational training | 68 (51%) | 15 (50%) | 39 (48%) | |||
| College/high school | 22 (17%) | 2 (7%) | 12 (15%) | |||
| University | 34 (26%) | 9 (30%) | 23 (28%) | |||
| Employment status | ||||||
| Employed | 46 (35%) | 16 (53%) | 47 (57%) | 0.056 | 0.001 | 0.707 |
| Insurance type (%) | ||||||
| Basic | 76 (57%) | 25 (83%) | 63 (77%) | 0.008 | 0.003 | 0.458 |
| Comorbidities (%) | 0.423 | 0.001 | 0.647 | |||
| None | 43 (32%) | 14 (47%) | 49 (60%) | |||
| 1 | 43 (32%) | 8 (27%) | 17 (21%) | |||
| 2 | 28 (21%) | 6 (20%) | 11 (13%) | |||
| >2 | 19 (14%) | 2 (7%) | 5 (6%) | |||
| Tumor stage (%) | 0.994 | 0.001 | 0.065 | |||
| I | 11 (10%) | 2 (9%) | 17 (25%) | |||
| II | 27 (24%) | 6 (26%) | 18 (27%) | |||
| III | 26 (23%) | 5 (22%) | 20 (30%) | |||
| IV | 51 (44%) | 10 (44%) | 12 (18%) | |||
| Cancer site (%) | 0.063 | <0.001 | <0.001 | |||
| Digestive organs | 49 (37%) | 6 (20%) | 4 (5%) | |||
| Thoracic organs | 20 (15%) | 2 (7%) | 5 (6%) | |||
| Head and neck | 22 (17%) | 13 (43%) | 13 (16%) | |||
| Hematological malignancies | 15 (11%) | 7 (23%) | 7 (9%) | |||
| Female genital organs | 7 (5%) | 1 (3%) | 11 (13%) | |||
| Sarcoma | 5 (4%) | 0 (0%) | 15 (18%) | |||
| Breast | 8 (6%) | 0 (0%) | 16 (20%) | |||
| Others | 7 (5%) | 1 (3%) | 11 (13%) | |||
| Cancer type (%) | 0.582 | 0.010 | 0.026 | |||
| Carcinoma | 101 (76%) | 21 (70%) | 50 (61%) | |||
| Sarcoma | 10 (8%) | 1 (3%) | 15(18%) | |||
| Myeloma | 8 (6%) | 3 (10%) | 4 (5%) | |||
| Lymphoma | 7 (5%) | 4 (13%) | 3 (4%) | |||
| Mesothelioma | 3 (2%) | 1 (3%) | 0 | |||
| Brain tumor | 3 (2%) | 0 (0%) | 8 (20%) | |||
| Others | 1 (1%) | 0 (0%) | 2 (2%) | |||
| Treatment type (%) d | 0.179 | 0008 | 0.597 | |||
| Surgery | 102 (77%) | 25 (83%) | 74 (90%) | |||
| Stem cell transplantation | 6 (5%) | 3 (10%) | 5 (6%) | |||
| Other | 24 (18%) | 2 (7%) | 3 (4%) | |||
| Physical therapy | ||||||
| Yes | 130 (98%) | 15 (50%) | 34 (42%) | <0.001 | <0.001 | 0.420 |
| Nutrition counselling | ||||||
| Yes | 78 (59%) | 11 (37%) | 10 (12%) | 0.029 | <0.001 | 0.003 |
| Psychological therapy | ||||||
| Yes | 42 (32%) | 2 (7%) | 6 (7%) | 0.005 | <0.001 | 1.000 |
N=245. a M /IQR: Median /interquartile range. b missing (n=53 only IG). c missing (n=48). d missing (n=1).